New Computer Monitor for Post-Concussion Syndrome

N/A

Recruiting

Led By Charles Tator, MD, PhD

Research Sponsored by University Health Network, Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up two visits 7 to 10 days apart

Summary

This trial tests if a new computer monitor is better tolerated by people with concussions, to improve understanding of concussion symptoms and help those affected.

Who is the study for?

This trial is for English-speaking adults aged 18-65 who have had concussion symptoms lasting from 1 month to 5 years. Participants must consent in writing and avoid alcohol or drugs for at least 24 hours before the intervention. Those with other neurological, psychiatric, or eye conditions cannot join.

What is being tested?

The study is testing a new computer monitor designed to be better tolerated by people with post-concussion syndrome compared to standard monitors. It aims to address issues like screen intolerance and light sensitivity in concussed patients.

What are the potential side effects?

Since this trial involves using a computer monitor, side effects are not typical as with medications; however, participants may experience discomfort if the screen does not alleviate their concussion-related symptoms.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ two visits 7 to 10 days apart

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~two visits 7 to 10 days apart

This trial's timeline: 3 weeks for screening, Varies for treatment, and two visits 7 to 10 days apart for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

The investigators believe that patients will subjectively perceive the new monitor to be a more effective reading device than the standard monitor.

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Newly designed computer monitorExperimental Treatment1 Intervention

Participants will read a short story and then watch moving images for 30 minutes or until any of their persisting concussion symptoms arise. The number and severity of symptoms will be assessed by completing SCAT -III pre- and post-study tasks.

Group II: Standard computer monitorPlacebo Group1 Intervention

Same participants will read a short story and watch moving images for 30 minutes or until any of their persisting concussion symptoms arise on the standard computer screen.The number and severity of symptoms will be assessed by completing SCAT -III pre- and post-study tasks.

Do I qualify?Apply below to find out